FDA Approves New Indication For Gardasil To Prevent Genital Warts In Men And Boys

The U.S. Food and Drug Administration approved use of the vaccine Gardasil for the prevention of genital warts (condyloma acuminata) due to human papillomavirus (HPV) types 6 and 11 in boys and men, ages 9 through 26. Each year, about 2 out of every 1,000 men in the United States are newly diagnosed with genital warts.

Sponsored by Internet Pharmacy - Indian Pharmacy, an online pharmacy supplies more than 600 quality generic medications, free prescription, worldwide shipping.

Canadian Pharmacy canada pharmacy

Related posts:

  1. FDA Approves GARDASIL(R) For Use In Boys And Young Men FDA Approves GARDASIL(R) For Use In Boys And Young Men Merck & Co., Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved GARDASIL® [Human Papillomavirus Quadrivalent...
  2. FDA Says GSK’s Cervarix Effective Against HPV; Gardasil Effective Against Male Warts FDA Says GSK’s Cervarix Effective Against HPV; Gardasil Effective Against Male Warts An FDA Advisory Committee meeting scheduled for this Wednesday will address GlaxoSmithKline’s application for approval of its human...
  3. FDA Panel Recommends Approval Of HPV Vaccine Cervarix For Women, Gardasil For Male Warts FDA Panel Recommends Approval Of HPV Vaccine Cervarix For Women, Gardasil For Male Warts An FDA panel on Wednesday recommended that the agency approve GlaxoSmithKline’s human papillomavirus vaccine, Cervarix, to...